Drug
ABBV-932 clinical trials
Also written ABBV-932.
Keep track of what changes. Save the ABBV-932 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- ABBV-932
- 10
Studies by the year they started
10 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ABBV-932 is read from its arms, and is right about nine times in ten.
Testing it · 10
- A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar DisorderRecruitingPhase 1AbbVieNCT07071532Written as ABBV-932
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderRecruitingPhase 2AbbVieNCT06846320Written as ABBV-932
- Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II DisorderCompletedPhase 2AbbVieNCT06605599Written as ABBV-932
- A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male ParticipantsCompletedPhase 1AbbVieNCT06953934Written as ABBV-932
- Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II DisorderActive, not recruitingPhase 2AbbVieNCT07220460Written as ABBV-932
- A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult ParticipantsCompletedPhase 1AbbVieNCT06849791Written as ABBV-932
- Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese ParticipantsCompletedPhase 1AbbVieNCT07024797Written as ABBV-932
- Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy VolunteersCompletedPhase 1AbbVieNCT06300580Written as ABBV-932
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)CompletedPhase 1AbbVieNCT06024239Written as ABBV-932
- Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult ParticipantsCompletedPhase 1AbbVieNCT05738850Written as ABBV-932